CD274 and neoplasm: Program death 1 (PD-1) is one of the major co-inhibitory checkpoints in the induction of immune suppression through binding of PD-1 receptor on activated T cells to its ligand, PD-L1, and on tumor cells, which significantly inhibit the killing activity of cytotoxic T lymphocytes (CTLs) (3).